To use all functions of this page, please activate cookies in your browser.
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Penetrance is a term used in genetics describing the proportion of individuals carrying a particular variation of a gene (an allele) that also express a particular trait (the phenotype). For example, Huntingtons disease has 95% penetrance, whereby 5% of those with the dominant allele for Huntingtons don't acquire the disease and 95% do. In other word, penetrance is the percentage of individuals with a specific genotype that possess an associated phenotype. For example, if 50% of the individuals carrying the "blue" allele are blue, the "blue" allele has 50% penetrance. Penetrance only considers whether individuals express the trait or not — for variation in the degree of expression of a given trait, see expressivity.
Additional recommended knowledge
If a allele is highly penetrant, the trait it produces will always or almost always be apparent in an individual carrying the allele. Reduced or incomplete penetrance occurs when some individuals fail to express the trait, even though they carry the allele. An allele with low penetrance will only sometimes produce the symptom or trait with which it has been associated at a detectable level. In the case of low penetrance it is difficult to distinguish environmental from genetic factors.
Common examples used to show degrees of penetrance are often highly penetrant. There are several reasons for this:
However, relatively few of the alleles in the genome show high penetrance. Traits such as height or intelligence are influenced by multiple genes as well as by environmental factors. Distribution of polygenic traits often falls along a bell curve.
The penetrance of some diseases is age-related. An example is multiple endocrine neoplasia 1 (MEN 1), a disorder characterized by parathyroid hyperplasia and pancreatic islet-cell and pituitary adenomas. It is due to a mutation in the menin gene on chromosome 11q13. In one study the age-related penetrance of MEN1 was 7 percent by age 10 years and nearly 100 percent by age 60 years.
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Penetrance". A list of authors is available in Wikipedia.|